CDEK by Data4ThePeople
IndicationsMechanismsTrialsFDA ApprovalsAbout
Sign in Sign up
IndicationsMechanismsTrialsFDA ApprovalsAbout

Chapter 2 - Neoplasms (C00-D49)»Malignant neoplasms of eye, brain and other parts of central nervous system (C69-C72)»Malignant neoplasm of brain (C71)

C71

Malignant neoplasm of brain

Sub-codes (10)

  • C71.0 Malignant neoplasm of cerebrum, except lobes and ventricles
  • C71.1 Malignant neoplasm of frontal lobe
  • C71.2 Malignant neoplasm of temporal lobe
  • C71.3 Malignant neoplasm of parietal lobe
  • C71.4 Malignant neoplasm of occipital lobe
  • C71.5 Malignant neoplasm of cerebral ventricle
  • C71.6 Malignant neoplasm of cerebellum

    1 indication for 1 drug

  • C71.7 Malignant neoplasm of brain stem
  • C71.8 Malignant neoplasm of overlapping sites of brain
  • C71.9 Malignant neoplasm of brain, unspecified

    1 indication for 591 drugs

CDEK

The Clinical Drug Experience Knowledgebase — tracking drugs, sponsoring organizations, and clinical trials from first-in-human testing through approval.

Browse

  • Drugs
  • Organizations
  • Trials

About

  • About CDEK
  • Glossary

Built and maintained by Data4ThePeople.

YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED "AS IS", WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.